Evidence map›Paper›PMID 34660301›Full record

ArticleFrontiers in oncology2021

Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients.

Hazem I Assi, Ibrahim A Alameh, Jessica Khoury, Maroun Bou Zerdan, Vanessa Akiki, Maya Charafeddine, Ghida I El Saheb, Fares Sukhon, Eman Sbaity, Serine Baydoun and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Hazem I AssiDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Ibrahim A AlamehDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Jessica KhouryDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Maroun Bou ZerdanDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Vanessa AkikiDepartment of Internal Medicine, Division of Endocrinology, American University of Beirut Medical Center, Beirut, Lebanon.
Maya CharafeddineDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Ghida I El SahebDepartment of Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Fares SukhonDepartment of Internal Medicine, Division of Hematology and Oncology, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Eman SbaityDepartment of General Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
Serine BaydounDepartment of Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Nina ShabbDepartment of Pathology, American University of Beirut Medical Center, Beirut, Lebanon.
Ghina BerjawiDepartment of Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Mohamad B HaidarDepartment of Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
American University of Beirut Medical Center · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to evaluate the diagnostic ability of 2-deoxy-2-[fluorine-18]fluoro-d-glucose ( PATIENTS AND

methodsPreoperative

resultsAxillary

conclusionThe diagnostic performance of

Indexed as

18F-FDG PET/CTaxillary lymph nodebreast cancerFNA (fine needle aspiration)ultrasonography

Identifiers

PMID34660301
PMCPMC8518554
OpenAlexW3204398509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.